BE (Biological E.)
PNEUBEVAX 14
₹ 3,195 / Piece
No Charges till Medical Approval
Summary: Pneubevax 14 – Pneumococcal Polysaccharide Conjugate Vaccine
Overview:
Pneubevax 14, produced by Biological E. Limited (BE), is a Pneumococcal Polysaccharide Conjugate Vaccine designed to protect against 14 serotypes of Streptococcus pneumoniae. It helps prevent pneumonia, meningitis, sepsis, and acute otitis media in infants.
How It Works:
This vaccine contains polysaccharides from the bacterial capsule, which help stimulate the immune system to develop protection against pneumococcal infections.
Administration:
- Given as a single injection in the anterolateral upper thigh.
- For infants >6 weeks old, administered as a 3-dose series at 6, 10, and 14 weeks.
- Not recommended for booster doses in the second year or later.
Side Effects:
- Pain or redness at the injection site
- Fever
- Muscle aches
- Fatigue
(Severe reactions are rare.)
Age Group:
- Minimum Age: >6 weeks
- Maximum Age: <1 year
Contraindications:
- Severe allergy to any vaccine component
- Severe acute febrile illness (postpone vaccination)
- Thrombocytopenia
- Immunocompromised individuals or those on immunosuppressive therapy
Pneubevax 14 is an essential part of early childhood immunization, reducing the risk of serious pneumococcal infections. Always consult a healthcare provider for vaccination guidance.
Prescription Compulsory
| Painless (gentle) | Mostly |
| < 6 month age | YES |
| 6mth-1yr age | YES |
| 1-2 yr | NO |
| Imported | NO |
| Doses | 3 |
| Antigens | 14 |
| Vaccine Type | Inactivated |
| Boosters | No |
| ACVIP 2020 Guidelines | Yes |
| >6wks -1 yrs | Yes |
| >12month age | No |
Pneubevax 14 is a Pneumococcal Polysaccharide Conjugate vaccine produced by Biological E. Limited (BE) used to protect against pneumococcal disease caused by 14 types of Streptococcus pneumoniae bacteria. This vaccine helps prevent infections such as pneumonia, meningitis, and sepsis, Acute Otitis Media.
How It Works
Pneubevax 14 contains polysaccharides from the bacteria's capsule, which stimulate the immune system to produce antibodies against these specific pneumococcal strains.
Administration
- Given as a single injection, usually in the anterolateral upper thigh.
- Only recommended for completion of primary vaccination schedule for infants >6 wk of age as 3 dose series, 6, 10, 14 wk.
- Not indicated for boosters in the 2nd year or thereafter.
Side Effects
Common side effects may include:
- Pain or redness at the injection site
- Fever
- Muscle aches
- Fatigue
Severe reactions are rare.
Pregnancy and Lactation
- Pregnancy: Not indicated in Adults
- Lactation: Not indicated in Adults
Minimum Age Group
- Minimum Age: Approved for use in infants >6 wk
Maximum Age Group
- Maximum Age: Approved for use in infants <1 yr.
Contraindications
- Allergic Reactions: Not for individuals with a severe allergy to any component of the vaccine.
- Severe Illness: Vaccination should be postponed in cases of acute, severe febrile illness.
- Thrombocytopenia, Immunocompromised individuals, Immunosuppressive therapy
Pneubevax 14 is essential for reducing the risk of serious pneumococcal diseases in infants and new borns. Always consult healthcare providers for personalized advice and recommendations.
Reviews and Ratings
No Customer Reviews
Share your thoughts with other customers
